NCI COVID-19 in Cancer Patients, NCCAPS Study

This study collects blood samples, medical information, and medical images from patients who
are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus
that causes the disease called COVID-19. Collecting blood samples, medical information, and
medical images may help researchers determine how COVID-19 affects the outcomes of patients
undergoing cancer treatment and how having cancer affects COVID-19.

Intervention

Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration

Condition

COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm

Investigators

Larissa A Korde

See list of participating sites